Equine Veterinary Therapeutics Market
A Detailed Analysis of Equine Veterinary Therapeutics Market by Topical & Veterinary Clinics
The Ultimate Guide to Business Growth with FMI’s Insights in Equine Veterinary Therapeutics Market
Equine Veterinary Therapeutics Market Outlook (2023 to 2033)
The global equine veterinary therapeutics market is expected to expand significantly and generate revenue of US$ 2,671.9 million by 2033 from US$ 1,378.7 million in 2023. This increase in revenue is made with an impressive CAGR value of 6.8%.
Historically the equine veterinary therapeutics market is generated US$ 1,307.6 million in 2022. There is expanding popularity of horse activities like racing and jumping which makes demand for equine veterinary therapeutics for care and treatment for horses if any horse gets any injury in these activities.
Equine veterinary therapy is a broad word that covers a wide range of horse therapies. These medicines have the potential to prevent, diagnose, and cure a wide range of diseases and medical conditions.
Horse owners are investing a large amount of money in the health of their animals as they are becoming more aware of the importance of care and treatment of their horses which brings the growth of the equine veterinary therapeutics market.
Regulations governing the use of horse veterinary medications have been established by governments. These rules are intended to ensure both the security and the effectiveness of these health care products. This is predicted to support the expansion of the equine veterinary treatments market, as owners of animals will be more willing to utilize medications that have received approval from the government.
| Report Attribute | Details |
|---|---|
| Equine Veterinary Therapeutics Market Value (2023) | US$ 1,378.7 million |
| Equine Veterinary Therapeutics Market Anticipated Forecast Value (2033) | US$ 2,671.9 million |
| Equine Veterinary Therapeutics Market Projected Growth Rate (2023 to 2033) | 6.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Historical Insights of Global Equine Veterinary Therapeutics Market (2017 to 2022)
The global equine veterinary therapeutics market expanded significantly from a revenue of US$ 1,052.2 million in 2017 to US$ 1,307.6 million in 2022 with an impressive CAGR of 4.4% during the historical period 2017 to 2022.
The global equestrian sports business is quickly expanding, which is fueling demand for equine veterinarian services. Horses are utilized in many sports, such as racing, show jumping, and dressage. These activities necessitate horses in peak physical condition, which increases the demand for preventative and therapeutic veterinary services.
Innovative Growth Strategies by Key Players to Thrive in the Competition
- Educate the public about equine health.
- Make use of digital platforms to reach a wider audience and provide better customer service.
- Develop new vaccines that are effective against emerging diseases.
- Focusing on customer satisfaction by offering demanded products, high-quality products and services.
- Expand in new markets to get new customers from new markets.
Investment Opportunities in the Industry
- Investing in research and development can stay ahead of the competition and meet the needs of horse owners and veterinarians.
- Investing in partnerships with other organizations helps to develop new products and services, and to reach a wider audience.
- Invest in sales and marketing, which will help to get more customers.
Regional Insights
The Rise of Equine Veterinary Therapeutics in North America
North America is the largest horse veterinary treatments market, accounting for 30.7% value share in global market. It is likely to expand more in the next decade. The veterinary treatments market in North America is expanding due to increased demand for anti-infectives, vaccinations, pain medications, digestive aids, and the strong research and development industry in North America, are driving the market.
| Country | The United States |
|---|---|
| 2022 value share in Global Market | 24.7% |
The Future of Equine Veterinary Therapeutics in Europe
The European market for horse veterinary medications is extremely fragmented and has a value share of 35.2% in 2022, with many small and medium-sized businesses. However, a few huge international corporations play a significant influence in the industry. Many Europe companies manufacture horse goods including immunizations, antibiotics, anti-inflammatory medicines, and pain medications.
| Country | United Kingdom |
|---|---|
| Value CAGR (2023 to 2033) | 4.8% |
| Country | Germany |
|---|---|
| 2022 value share in Global Market | 6.2% |
Asia Pacific is Riding the Wave of Growth in the Equine Veterinary Therapeutics Market
The adoption of technology is also playing a significant role in the growth of the Asia Pacific equine veterinary therapeutics market. New technologies are being developed that have the potential to transform the treatment of horse illnesses, like gene therapy, immunotherapy, and customized medicine. These technologies are projected to play a significant role in market growth in the future years in the region.
| Country | Japan |
|---|---|
| 2022 value share in Global Market | 4.4% |
| Country | Value CAGR (2023 to 2033) |
|---|---|
| China | 8.3% |
| India | 6.8% |
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
Segment-wise Insights
| Segment Name | Segment Share |
|---|---|
| Topical | 43.2 |
| Veterinary Clinics | 40.5 |
With the increased demand for anti-infectives, pain relievers, and digestive aid products, the topical section of the veterinary treatments market is expanding and has a segment share of 43.2%. The rising frequency of infectious illnesses, rising prevalence of chronic diseases, and rising pet obesity rates are all boosting demand for these items.
With rising demand for surgery, diagnostic testing, and preventive care, the veterinary clinics sector of the veterinary treatments market is expanding and has a segment share of 40.5%. The rising prevalence of animal injuries and diseases, the increased availability of diagnostic testing, and the expanding understanding of the value of preventative treatment are all boosting demand for these services.
Recent Developments
- January 2023: Apoquel Tablets have been launched by Zoetis Inc. for the relief of atopic dermatitis in dogs and cats. Apoquel is a topical drug that acts by inhibiting the function of interleukin-13, a type of protein that is implicated in the growth of allergic skin irritation.
- February 2023: Clavamox Soluble Oral Suspension has been launched by Boehringer Ingelheim Animal Health for the prevention and management of respiratory diseases in horses. Clavamox Soluble is a combined antibiotic that works against a variety of bacteria that cause respiratory infections in horses.
- April 2023: Convenia Injectable Suspension has been launched by Elanco Animal Health for the relief of respiratory diseases in horses. Convenia is a powerful antibiotic that works against a variety of bacteria which may lead to respiratory infections in horses.
- September 2022: Merck Animal Health has introduced Credelio Spot-On for flea and tick treatment in dogs. Credelio is a monthly spot-on therapy which is simple to use and works well against these types of parasites.
- December 2022: Merck Animal Health has introduced Bravecto Topical Gel to fight fleas and ticks in cats. Bravecto is a monthly topical gel which is simple to use and offers good parasite prevention.
The Key Players in the Equine Veterinary Therapeutics Market
- Merck Animal Heath
- Affymetrix
- Elanco Animal Health
- Zoetis (Pfizer Animal Health)
- Equine Health UK
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Segments Profiled in the Equine Veterinary Therapeutics Market Survey
By Drugs:
- Anti- Inflammatory
- Anti - Infective
- Parasiticides
- Others
By Vaccines:
- Recombinant vaccines
- Inactivated Vaccines
- Live attenuated vaccines
- Others
By Feed Additives:
- Vitamins
- Antibiotics
- Amino acids
- Enzymes
- Others
By Route of Administration:
- Oral
- Parental
- Topical
By Distribution Channel:
- Veterinary Hospital
- Veterinary Clinics
- Pharmacies and drug stores
- E-commerce
- Other
By Region:
- North America
- Latin America
- The Asia Pacific
- MEA
- Europe
Frequently Asked Questions
What is the growth rate of the equine veterinary therapeutics market from 2023 to 2033?
The equine veterinary therapeutics market is expected to expand at a CAGR of 6.8% from 2023 to 2033.
Which region is leading the global equine veterinary therapeutics market?
North America is the leading region in the global equine veterinary therapeutics market.
What is the market size of the global equine veterinary therapeutics market in 2023?
The global equine veterinary therapeutics market was valued at US$ 1,378.7 million in 2023.
What does the anticipated revenue of the equine veterinary therapeutics market until 2033?
The anticipated revenue of the equine veterinary therapeutics market until 2033 is US$ 2,671.9 million.
Which are some prominent equine veterinary therapeutics market manufacturers?
Zoetis, Boehringer Ingelheim, Merck Animal Health, Virbac, Elanco Animal Health, and Ceva Animal Health are prominent market manufacturers.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drugs 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Drugs, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drugs, 2023 to 2033 5.3.1. Anti- Inflammatory 5.3.2. Anti – Infective 5.3.3. Parasiticides 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Drugs, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Drugs, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Vaccines 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Vaccines, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Vaccines, 2023 to 2033 6.3.1. Recombinant vaccines 6.3.2. Inactivated Vaccines 6.3.3. Live attenuated vaccines 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Vaccines, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Vaccines, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Feed Additives 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Feed Additives, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Feed Additives, 2023 to 2033 7.3.1. Vitamins 7.3.2. Antibiotics 7.3.3. Amino acids 7.3.4. Enzymes 7.3.5. Others 7.4. Y-o-Y Growth Trend Analysis By Feed Additives, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Feed Additives, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033 8.3.1. Oral 8.3.2. Parental 8.3.3. Topical 8.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 9.3.1. Veterinary Hospital 9.3.2. Veterinary Clinics 9.3.3. Pharmacies and drug stores 9.3.4. E-commerce 9.3.5. Other 9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Western Europe 10.3.4. Eastern Europe 10.3.5. South Asia and Pacific 10.3.6. East Asia 10.3.7. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. USA 11.2.1.2. Canada 11.2.2. By Drugs 11.2.3. By Vaccines 11.2.4. By Feed Additives 11.2.5. By Route of Administration 11.2.6. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Drugs 11.3.3. By Vaccines 11.3.4. By Feed Additives 11.3.5. By Route of Administration 11.3.6. By Distribution Channel 11.4. Key Takeaways 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Drugs 12.2.3. By Vaccines 12.2.4. By Feed Additives 12.2.5. By Route of Administration 12.2.6. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Drugs 12.3.3. By Vaccines 12.3.4. By Feed Additives 12.3.5. By Route of Administration 12.3.6. By Distribution Channel 12.4. Key Takeaways 13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. UK 13.2.1.3. France 13.2.1.4. Spain 13.2.1.5. Italy 13.2.1.6. Rest of Western Europe 13.2.2. By Drugs 13.2.3. By Vaccines 13.2.4. By Feed Additives 13.2.5. By Route of Administration 13.2.6. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Drugs 13.3.3. By Vaccines 13.3.4. By Feed Additives 13.3.5. By Route of Administration 13.3.6. By Distribution Channel 13.4. Key Takeaways 14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Poland 14.2.1.2. Russia 14.2.1.3. Czech Republic 14.2.1.4. Romania 14.2.1.5. Rest of Eastern Europe 14.2.2. By Drugs 14.2.3. By Vaccines 14.2.4. By Feed Additives 14.2.5. By Route of Administration 14.2.6. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Drugs 14.3.3. By Vaccines 14.3.4. By Feed Additives 14.3.5. By Route of Administration 14.3.6. By Distribution Channel 14.4. Key Takeaways 15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Bangladesh 15.2.1.3. Australia 15.2.1.4. New Zealand 15.2.1.5. Rest of South Asia and Pacific 15.2.2. By Drugs 15.2.3. By Vaccines 15.2.4. By Feed Additives 15.2.5. By Route of Administration 15.2.6. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Drugs 15.3.3. By Vaccines 15.3.4. By Feed Additives 15.3.5. By Route of Administration 15.3.6. By Distribution Channel 15.4. Key Takeaways 16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. China 16.2.1.2. Japan 16.2.1.3. South Korea 16.2.2. By Drugs 16.2.3. By Vaccines 16.2.4. By Feed Additives 16.2.5. By Route of Administration 16.2.6. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Drugs 16.3.3. By Vaccines 16.3.4. By Feed Additives 16.3.5. By Route of Administration 16.3.6. By Distribution Channel 16.4. Key Takeaways 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 17.2.1. By Country 17.2.1.1. GCC Countries 17.2.1.2. South Africa 17.2.1.3. Israel 17.2.1.4. Rest of MEA 17.2.2. By Drugs 17.2.3. By Vaccines 17.2.4. By Feed Additives 17.2.5. By Route of Administration 17.2.6. By Distribution Channel 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Drugs 17.3.3. By Vaccines 17.3.4. By Feed Additives 17.3.5. By Route of Administration 17.3.6. By Distribution Channel 17.4. Key Takeaways 18. Key Countries Market Analysis 18.1. USA 18.1.1. Pricing Analysis 18.1.2. Market Share Analysis, 2022 18.1.2.1. By Drugs 18.1.2.2. By Vaccines 18.1.2.3. By Feed Additives 18.1.2.4. By Route of Administration 18.1.2.5. By Distribution Channel 18.2. Canada 18.2.1. Pricing Analysis 18.2.2. Market Share Analysis, 2022 18.2.2.1. By Drugs 18.2.2.2. By Vaccines 18.2.2.3. By Feed Additives 18.2.2.4. By Route of Administration 18.2.2.5. By Distribution Channel 18.3. Brazil 18.3.1. Pricing Analysis 18.3.2. Market Share Analysis, 2022 18.3.2.1. By Drugs 18.3.2.2. By Vaccines 18.3.2.3. By Feed Additives 18.3.2.4. By Route of Administration 18.3.2.5. By Distribution Channel 18.4. Mexico 18.4.1. Pricing Analysis 18.4.2. Market Share Analysis, 2022 18.4.2.1. By Drugs 18.4.2.2. By Vaccines 18.4.2.3. By Feed Additives 18.4.2.4. By Route of Administration 18.4.2.5. By Distribution Channel 18.5. Germany 18.5.1. Pricing Analysis 18.5.2. Market Share Analysis, 2022 18.5.2.1. By Drugs 18.5.2.2. By Vaccines 18.5.2.3. By Feed Additives 18.5.2.4. By Route of Administration 18.5.2.5. By Distribution Channel 18.6. UK 18.6.1. Pricing Analysis 18.6.2. Market Share Analysis, 2022 18.6.2.1. By Drugs 18.6.2.2. By Vaccines 18.6.2.3. By Feed Additives 18.6.2.4. By Route of Administration 18.6.2.5. By Distribution Channel 18.7. France 18.7.1. Pricing Analysis 18.7.2. Market Share Analysis, 2022 18.7.2.1. By Drugs 18.7.2.2. By Vaccines 18.7.2.3. By Feed Additives 18.7.2.4. By Route of Administration 18.7.2.5. By Distribution Channel 18.8. Spain 18.8.1. Pricing Analysis 18.8.2. Market Share Analysis, 2022 18.8.2.1. By Drugs 18.8.2.2. By Vaccines 18.8.2.3. By Feed Additives 18.8.2.4. By Route of Administration 18.8.2.5. By Distribution Channel 18.9. Italy 18.9.1. Pricing Analysis 18.9.2. Market Share Analysis, 2022 18.9.2.1. By Drugs 18.9.2.2. By Vaccines 18.9.2.3. By Feed Additives 18.9.2.4. By Route of Administration 18.9.2.5. By Distribution Channel 18.10. Poland 18.10.1. Pricing Analysis 18.10.2. Market Share Analysis, 2022 18.10.2.1. By Drugs 18.10.2.2. By Vaccines 18.10.2.3. By Feed Additives 18.10.2.4. By Route of Administration 18.10.2.5. By Distribution Channel 18.11. Russia 18.11.1. Pricing Analysis 18.11.2. Market Share Analysis, 2022 18.11.2.1. By Drugs 18.11.2.2. By Vaccines 18.11.2.3. By Feed Additives 18.11.2.4. By Route of Administration 18.11.2.5. By Distribution Channel 18.12. Czech Republic 18.12.1. Pricing Analysis 18.12.2. Market Share Analysis, 2022 18.12.2.1. By Drugs 18.12.2.2. By Vaccines 18.12.2.3. By Feed Additives 18.12.2.4. By Route of Administration 18.12.2.5. By Distribution Channel 18.13. Romania 18.13.1. Pricing Analysis 18.13.2. Market Share Analysis, 2022 18.13.2.1. By Drugs 18.13.2.2. By Vaccines 18.13.2.3. By Feed Additives 18.13.2.4. By Route of Administration 18.13.2.5. By Distribution Channel 18.14. India 18.14.1. Pricing Analysis 18.14.2. Market Share Analysis, 2022 18.14.2.1. By Drugs 18.14.2.2. By Vaccines 18.14.2.3. By Feed Additives 18.14.2.4. By Route of Administration 18.14.2.5. By Distribution Channel 18.15. Bangladesh 18.15.1. Pricing Analysis 18.15.2. Market Share Analysis, 2022 18.15.2.1. By Drugs 18.15.2.2. By Vaccines 18.15.2.3. By Feed Additives 18.15.2.4. By Route of Administration 18.15.2.5. By Distribution Channel 18.16. Australia 18.16.1. Pricing Analysis 18.16.2. Market Share Analysis, 2022 18.16.2.1. By Drugs 18.16.2.2. By Vaccines 18.16.2.3. By Feed Additives 18.16.2.4. By Route of Administration 18.16.2.5. By Distribution Channel 18.17. New Zealand 18.17.1. Pricing Analysis 18.17.2. Market Share Analysis, 2022 18.17.2.1. By Drugs 18.17.2.2. By Vaccines 18.17.2.3. By Feed Additives 18.17.2.4. By Route of Administration 18.17.2.5. By Distribution Channel 18.18. China 18.18.1. Pricing Analysis 18.18.2. Market Share Analysis, 2022 18.18.2.1. By Drugs 18.18.2.2. By Vaccines 18.18.2.3. By Feed Additives 18.18.2.4. By Route of Administration 18.18.2.5. By Distribution Channel 18.19. Japan 18.19.1. Pricing Analysis 18.19.2. Market Share Analysis, 2022 18.19.2.1. By Drugs 18.19.2.2. By Vaccines 18.19.2.3. By Feed Additives 18.19.2.4. By Route of Administration 18.19.2.5. By Distribution Channel 18.20. South Korea 18.20.1. Pricing Analysis 18.20.2. Market Share Analysis, 2022 18.20.2.1. By Drugs 18.20.2.2. By Vaccines 18.20.2.3. By Feed Additives 18.20.2.4. By Route of Administration 18.20.2.5. By Distribution Channel 18.21. GCC Countries 18.21.1. Pricing Analysis 18.21.2. Market Share Analysis, 2022 18.21.2.1. By Drugs 18.21.2.2. By Vaccines 18.21.2.3. By Feed Additives 18.21.2.4. By Route of Administration 18.21.2.5. By Distribution Channel 18.22. South Africa 18.22.1. Pricing Analysis 18.22.2. Market Share Analysis, 2022 18.22.2.1. By Drugs 18.22.2.2. By Vaccines 18.22.2.3. By Feed Additives 18.22.2.4. By Route of Administration 18.22.2.5. By Distribution Channel 18.23. Israel 18.23.1. Pricing Analysis 18.23.2. Market Share Analysis, 2022 18.23.2.1. By Drugs 18.23.2.2. By Vaccines 18.23.2.3. By Feed Additives 18.23.2.4. By Route of Administration 18.23.2.5. By Distribution Channel 19. Market Structure Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Market Share Analysis of Top Players 19.3.1. By Regional 19.3.2. By Drugs 19.3.3. By Vaccines 19.3.4. By Feed Additives 19.3.5. By Route of Administration 19.3.6. By Distribution Channel 20. Competition Analysis 20.1. Competition Deep Dive 20.1.1. Merck Animal Heath 20.1.1.1. Overview 20.1.1.2. Product Portfolio 20.1.1.3. Profitability by Market Segments 20.1.1.4. Sales Footprint 20.1.1.5. Strategy Overview 20.1.1.5.1. Marketing Strategy 20.1.2. Affymetrix 20.1.2.1. Overview 20.1.2.2. Product Portfolio 20.1.2.3. Profitability by Market Segments 20.1.2.4. Sales Footprint 20.1.2.5. Strategy Overview 20.1.2.5.1. Marketing Strategy 20.1.3. Elanco Animal Health 20.1.3.1. Overview 20.1.3.2. Product Portfolio 20.1.3.3. Profitability by Market Segments 20.1.3.4. Sales Footprint 20.1.3.5. Strategy Overview 20.1.3.5.1. Marketing Strategy 20.1.4. Zoetis (Pfizer Animal Health) 20.1.4.1. Overview 20.1.4.2. Product Portfolio 20.1.4.3. Profitability by Market Segments 20.1.4.4. Sales Footprint 20.1.4.5. Strategy Overview 20.1.4.5.1. Marketing Strategy 20.1.5. Equine Health UK 20.1.5.1. Overview 20.1.5.2. Product Portfolio 20.1.5.3. Profitability by Market Segments 20.1.5.4. Sales Footprint 20.1.5.5. Strategy Overview 20.1.5.5.1. Marketing Strategy 20.1.6. Olympia Equine Veterinary Services PLLC 20.1.6.1. Overview 20.1.6.2. Product Portfolio 20.1.6.3. Profitability by Market Segments 20.1.6.4. Sales Footprint 20.1.6.5. Strategy Overview 20.1.6.5.1. Marketing Strategy 20.1.7. Ceva Sante Animale 20.1.7.1. Overview 20.1.7.2. Product Portfolio 20.1.7.3. Profitability by Market Segments 20.1.7.4. Sales Footprint 20.1.7.5. Strategy Overview 20.1.7.5.1. Marketing Strategy 20.1.8. Eli Lilly and Company 20.1.8.1. Overview 20.1.8.2. Product Portfolio 20.1.8.3. Profitability by Market Segments 20.1.8.4. Sales Footprint 20.1.8.5. Strategy Overview 20.1.8.5.1. Marketing Strategy 20.1.9. Virbac 20.1.9.1. Overview 20.1.9.2. Product Portfolio 20.1.9.3. Profitability by Market Segments 20.1.9.4. Sales Footprint 20.1.9.5. Strategy Overview 20.1.9.5.1. Marketing Strategy 20.1.10. Bayer AG 20.1.10.1. Overview 20.1.10.2. Product Portfolio 20.1.10.3. Profitability by Market Segments 20.1.10.4. Sales Footprint 20.1.10.5. Strategy Overview 20.1.10.5.1. Marketing Strategy 21. Assumptions & Acronyms Used 22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Drugs, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 6: Global Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Drugs, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033 Table 10: North America Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033 Table 11: North America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 12: North America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Latin America Market Value (US$ Million) Forecast by Drugs, 2018 to 2033 Table 15: Latin America Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033 Table 16: Latin America Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033 Table 17: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 18: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 20: Western Europe Market Value (US$ Million) Forecast by Drugs, 2018 to 2033 Table 21: Western Europe Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033 Table 22: Western Europe Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033 Table 23: Western Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 24: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: Eastern Europe Market Value (US$ Million) Forecast by Drugs, 2018 to 2033 Table 27: Eastern Europe Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033 Table 28: Eastern Europe Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033 Table 29: Eastern Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 30: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 32: South Asia and Pacific Market Value (US$ Million) Forecast by Drugs, 2018 to 2033 Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033 Table 34: South Asia and Pacific Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033 Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 36: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 38: East Asia Market Value (US$ Million) Forecast by Drugs, 2018 to 2033 Table 39: East Asia Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033 Table 40: East Asia Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033 Table 41: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 42: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 44: Middle East and Africa Market Value (US$ Million) Forecast by Drugs, 2018 to 2033 Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033 Table 46: Middle East and Africa Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033 Table 47: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 48: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Drugs, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Vaccines, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Feed Additives, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 5: Global Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 6: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 7: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 10: Global Market Value (US$ Million) Analysis by Drugs, 2018 to 2033 Figure 11: Global Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033 Figure 12: Global Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033 Figure 13: Global Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033 Figure 14: Global Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033 Figure 15: Global Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033 Figure 16: Global Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033 Figure 17: Global Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033 Figure 18: Global Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033 Figure 19: Global Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 20: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 21: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 22: Global Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 23: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 24: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 25: Global Market Attractiveness by Drugs, 2023 to 2033 Figure 26: Global Market Attractiveness by Vaccines, 2023 to 2033 Figure 27: Global Market Attractiveness by Feed Additives, 2023 to 2033 Figure 28: Global Market Attractiveness by Route of Administration, 2023 to 2033 Figure 29: Global Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 30: Global Market Attractiveness by Region, 2023 to 2033 Figure 31: North America Market Value (US$ Million) by Drugs, 2023 to 2033 Figure 32: North America Market Value (US$ Million) by Vaccines, 2023 to 2033 Figure 33: North America Market Value (US$ Million) by Feed Additives, 2023 to 2033 Figure 34: North America Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 35: North America Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 36: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 40: North America Market Value (US$ Million) Analysis by Drugs, 2018 to 2033 Figure 41: North America Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033 Figure 42: North America Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033 Figure 43: North America Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033 Figure 46: North America Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033 Figure 47: North America Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033 Figure 48: North America Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033 Figure 49: North America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 50: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 51: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 52: North America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 53: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 54: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 55: North America Market Attractiveness by Drugs, 2023 to 2033 Figure 56: North America Market Attractiveness by Vaccines, 2023 to 2033 Figure 57: North America Market Attractiveness by Feed Additives, 2023 to 2033 Figure 58: North America Market Attractiveness by Route of Administration, 2023 to 2033 Figure 59: North America Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 60: North America Market Attractiveness by Country, 2023 to 2033 Figure 61: Latin America Market Value (US$ Million) by Drugs, 2023 to 2033 Figure 62: Latin America Market Value (US$ Million) by Vaccines, 2023 to 2033 Figure 63: Latin America Market Value (US$ Million) by Feed Additives, 2023 to 2033 Figure 64: Latin America Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 65: Latin America Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 66: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 67: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 70: Latin America Market Value (US$ Million) Analysis by Drugs, 2018 to 2033 Figure 71: Latin America Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033 Figure 72: Latin America Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033 Figure 73: Latin America Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033 Figure 74: Latin America Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033 Figure 75: Latin America Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033 Figure 76: Latin America Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033 Figure 77: Latin America Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033 Figure 78: Latin America Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033 Figure 79: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 80: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 82: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 83: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 84: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 85: Latin America Market Attractiveness by Drugs, 2023 to 2033 Figure 86: Latin America Market Attractiveness by Vaccines, 2023 to 2033 Figure 87: Latin America Market Attractiveness by Feed Additives, 2023 to 2033 Figure 88: Latin America Market Attractiveness by Route of Administration, 2023 to 2033 Figure 89: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 90: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 91: Western Europe Market Value (US$ Million) by Drugs, 2023 to 2033 Figure 92: Western Europe Market Value (US$ Million) by Vaccines, 2023 to 2033 Figure 93: Western Europe Market Value (US$ Million) by Feed Additives, 2023 to 2033 Figure 94: Western Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 95: Western Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 96: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 97: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 100: Western Europe Market Value (US$ Million) Analysis by Drugs, 2018 to 2033 Figure 101: Western Europe Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033 Figure 102: Western Europe Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033 Figure 103: Western Europe Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033 Figure 104: Western Europe Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033 Figure 105: Western Europe Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033 Figure 106: Western Europe Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033 Figure 107: Western Europe Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033 Figure 108: Western Europe Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033 Figure 109: Western Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 110: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 112: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 113: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 114: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 115: Western Europe Market Attractiveness by Drugs, 2023 to 2033 Figure 116: Western Europe Market Attractiveness by Vaccines, 2023 to 2033 Figure 117: Western Europe Market Attractiveness by Feed Additives, 2023 to 2033 Figure 118: Western Europe Market Attractiveness by Route of Administration, 2023 to 2033 Figure 119: Western Europe Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 120: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 121: Eastern Europe Market Value (US$ Million) by Drugs, 2023 to 2033 Figure 122: Eastern Europe Market Value (US$ Million) by Vaccines, 2023 to 2033 Figure 123: Eastern Europe Market Value (US$ Million) by Feed Additives, 2023 to 2033 Figure 124: Eastern Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 125: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 126: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 127: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Drugs, 2018 to 2033 Figure 131: Eastern Europe Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033 Figure 132: Eastern Europe Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033 Figure 133: Eastern Europe Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033 Figure 134: Eastern Europe Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033 Figure 135: Eastern Europe Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033 Figure 136: Eastern Europe Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033 Figure 137: Eastern Europe Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033 Figure 138: Eastern Europe Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033 Figure 139: Eastern Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 142: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 143: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 144: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 145: Eastern Europe Market Attractiveness by Drugs, 2023 to 2033 Figure 146: Eastern Europe Market Attractiveness by Vaccines, 2023 to 2033 Figure 147: Eastern Europe Market Attractiveness by Feed Additives, 2023 to 2033 Figure 148: Eastern Europe Market Attractiveness by Route of Administration, 2023 to 2033 Figure 149: Eastern Europe Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 150: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 151: South Asia and Pacific Market Value (US$ Million) by Drugs, 2023 to 2033 Figure 152: South Asia and Pacific Market Value (US$ Million) by Vaccines, 2023 to 2033 Figure 153: South Asia and Pacific Market Value (US$ Million) by Feed Additives, 2023 to 2033 Figure 154: South Asia and Pacific Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 155: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 156: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 157: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Drugs, 2018 to 2033 Figure 161: South Asia and Pacific Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033 Figure 162: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033 Figure 163: South Asia and Pacific Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033 Figure 164: South Asia and Pacific Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033 Figure 165: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033 Figure 166: South Asia and Pacific Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033 Figure 167: South Asia and Pacific Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033 Figure 168: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033 Figure 169: South Asia and Pacific Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 173: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 174: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 175: South Asia and Pacific Market Attractiveness by Drugs, 2023 to 2033 Figure 176: South Asia and Pacific Market Attractiveness by Vaccines, 2023 to 2033 Figure 177: South Asia and Pacific Market Attractiveness by Feed Additives, 2023 to 2033 Figure 178: South Asia and Pacific Market Attractiveness by Route of Administration, 2023 to 2033 Figure 179: South Asia and Pacific Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 180: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 181: East Asia Market Value (US$ Million) by Drugs, 2023 to 2033 Figure 182: East Asia Market Value (US$ Million) by Vaccines, 2023 to 2033 Figure 183: East Asia Market Value (US$ Million) by Feed Additives, 2023 to 2033 Figure 184: East Asia Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 185: East Asia Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 186: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 187: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 190: East Asia Market Value (US$ Million) Analysis by Drugs, 2018 to 2033 Figure 191: East Asia Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033 Figure 192: East Asia Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033 Figure 193: East Asia Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033 Figure 194: East Asia Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033 Figure 195: East Asia Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033 Figure 196: East Asia Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033 Figure 197: East Asia Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033 Figure 198: East Asia Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033 Figure 199: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 200: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 201: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 202: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 203: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 204: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 205: East Asia Market Attractiveness by Drugs, 2023 to 2033 Figure 206: East Asia Market Attractiveness by Vaccines, 2023 to 2033 Figure 207: East Asia Market Attractiveness by Feed Additives, 2023 to 2033 Figure 208: East Asia Market Attractiveness by Route of Administration, 2023 to 2033 Figure 209: East Asia Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 210: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 211: Middle East and Africa Market Value (US$ Million) by Drugs, 2023 to 2033 Figure 212: Middle East and Africa Market Value (US$ Million) by Vaccines, 2023 to 2033 Figure 213: Middle East and Africa Market Value (US$ Million) by Feed Additives, 2023 to 2033 Figure 214: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 215: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 216: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 217: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Drugs, 2018 to 2033 Figure 221: Middle East and Africa Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033 Figure 222: Middle East and Africa Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033 Figure 223: Middle East and Africa Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033 Figure 224: Middle East and Africa Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033 Figure 225: Middle East and Africa Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033 Figure 226: Middle East and Africa Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033 Figure 227: Middle East and Africa Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033 Figure 228: Middle East and Africa Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033 Figure 229: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 233: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 234: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 235: Middle East and Africa Market Attractiveness by Drugs, 2023 to 2033 Figure 236: Middle East and Africa Market Attractiveness by Vaccines, 2023 to 2033 Figure 237: Middle East and Africa Market Attractiveness by Feed Additives, 2023 to 2033 Figure 238: Middle East and Africa Market Attractiveness by Route of Administration, 2023 to 2033 Figure 239: Middle East and Africa Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 240: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
